BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9614372)

  • 1. The development of haematopathology laboratories: a possible model for other pathology services.
    Jack AS; Morgan GJ
    J Pathol; 1998 Mar; 184(3):231-3. PubMed ID: 9614372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organisation of neoplastic haematopathology services: a UK perspective.
    Jack A
    Pathology; 2005 Dec; 37(6):479-92. PubMed ID: 16373228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
    Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
    J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care.
    Ireland R
    Histopathology; 2011 Jan; 58(1):145-54. PubMed ID: 21261689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma.
    Richards SJ; Jack AS
    Clin Lab Haematol; 2003 Dec; 25(6):337-42. PubMed ID: 14641135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics].
    Paulli M; Artusi T; Baroni CD; Carbone A; Coggi G; Di Lollo S; Facchetti F; Falini B; Franco V; Gambacorta M; La Rocca VM; Leoncini L; Magrini U; Maiorana A; Menestrina F; Novero D; Palestro G; Pescarmona E; Santucci M; Stracca Pansa V; Truini M; Pileri S
    Pathologica; 2006 Feb; 98(1):37-40. PubMed ID: 16789684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
    Bench AJ; Erber WN; Scott MA
    Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular hematology. Qualitative to quantitative techniques.
    Khalil SH
    Saudi Med J; 2005 Oct; 26(10):1516-22. PubMed ID: 16228048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
    Drénou B; Fardel O; Fauchet R; Amiot L
    Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnosis and new gene engineering in hematological malignancies].
    Funato T; Fujiwara J; Fujimaki S; Kaku M
    Rinsho Byori; 2000 Oct; 48(10):887-91. PubMed ID: 11215098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frozen sections in hematopathology.
    Solomon AC; Kossev PM
    Semin Diagn Pathol; 2002 Nov; 19(4):255-62. PubMed ID: 12469792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphology and immunophenotyping in hematological malignancies].
    Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
    Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Scottish molecular genetics consortium--15 years on.
    Kelly KF
    Health Bull (Edinb); 2002 Jan; 60(1):83-90. PubMed ID: 12664773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making the most of your hematology proficiency surveys.
    Gheen DL
    MLO Med Lab Obs; 1993 Dec; 25(12):30-1. PubMed ID: 10145943
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern molecular diagnostics and the management of haematological malignancies.
    Morgan GJ; Pratt G
    Clin Lab Haematol; 1998 Jun; 20(3):135-41. PubMed ID: 9681227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pathology Laboratory Act 2007 explained.
    Looi LM
    Malays J Pathol; 2008 Jun; 30(1):1-10. PubMed ID: 19108405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy for diagnosing hematological malignancies--a proposal from hematologists to laboratory medicine].
    Miyazaki Y; Kuriyama K
    Rinsho Byori; 2000 Aug; 48(8):685-8. PubMed ID: 11064589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimising therapy in patients with haematological malignancies].
    Dumontet C
    Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synoptic tool for reporting of hematological and lymphoid neoplasms based on World Health Organization classification and College of American Pathologists checklist.
    Mohanty SK; Piccoli AL; Devine LJ; Patel AA; William GC; Winters SB; Becich MJ; Parwani AV
    BMC Cancer; 2007 Jul; 7():144. PubMed ID: 17672904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.